Search

everythinglearnresearchcommunity

for

Search:↓

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Treated hair can fight dandruff and odor even after several washes.

Vitamin D3 may protect rat hair follicles from radiation damage.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Shaving, erythromycin cream, and clotrimazole powder effectively treated the bad odor and rough hair.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

New cancer treatments aim to reduce side effects and improve effectiveness.

N,N-Dimethylglycine Sodium Salt helps reduce skin inflammation and improves skin cell growth and healing.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Compound 7p shows strong potential as an anticancer agent.

Diphencyprone therapy for hair loss can cause vitiligo.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

Diclofenac salt delivery through skin varies based on the salt's counterions.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Diammonium glycyrrhizinate at 0.01 μmol/L promotes hair growth by activating the Wnt/β-catenin pathway.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Adenosine can help treat hair loss by promoting hair growth.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.